Local treatment of viral disease using photodynamic therapy.
Although reports of the photodynamic inactivation of viruses appeared in 1928, long before chemotherapeutic antiviral drugs, the first clinical trial in humans-the topical treatment of herpes genitalis-did not take place until the early 1970s. Trials were discontinued due to the transformation of healthy cells and concomitant incidence of Bowen's disease in some patients, probably due to the migration of infective sections of photodamaged viral nucleic acid. With the modern development of photodynamic therapy as a cancer treatment and the use of photosensitisers in the photodecontamination of blood products, a great deal of experience has been gained, both in the minimisation of side effects in humans and in the targeting and eradication of viruses. This suggests that the photodynamic approach to a range of virus-associated infections, lesions and cancer might now be revisited with greater success.
Wainwright
Mark
M
Department of Colour Chemistry, Centre for Photobiology and Photodynamic Therapy, The University, LS2 9JT, Leeds, UK. ccdmw@leeds.ac.uk
D006801:Humans; D010778:Photochemotherapy; D014777:Virus Diseases / Q000188:drug therapy*